Skip to main content
Basilea Pharmaceutica AG (SWX: BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
40.35
+0.60 (1.51%)
Nov 20, 2024, 5:30 PM CET

Basilea Pharmaceutica AG Revenue

Basilea Pharmaceutica AG had revenue of 76.29M CHF in the half year ending June 30, 2024, with 32.35% growth. This brings the company's revenue in the last twelve months to 149.02M, down -14.86% year-over-year. In the year 2023, Basilea Pharmaceutica AG had annual revenue of 157.63M with 6.68% growth.

Revenue (ttm)
149.02M
Revenue Growth
-14.86%
P/S Ratio
3.26
Revenue / Employee
955.27K
Employees
147
Market Cap
489.09M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023157.63M9.87M6.68%
Dec 31, 2022147.77M-357.00K-0.24%
Dec 31, 2021148.12M20.49M16.06%
Dec 31, 2020127.63M-6.75M-5.02%
Dec 31, 2019134.38M1.83M1.38%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 60.58B
Roche Holding AG 60.58B
Novartis AG 42.18B
Lonza Group AG 6.70B
Galderma Group AG 3.88B
Sonova Holding AG 3.71B
Straumann Holding AG 2.54B
Ypsomed Holding AG 548.53M
Revenue Rankings

Basilea Pharmaceutica AG News

More News